GSK Stock: Price, Earnings History and SEC Filings
GSK plc (GSK) last traded at $49.51, up 1.71% on the latest session and up 2.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.47 against an analyst estimate of $1.40, a beat of 5.0%.
$49.51 +1.71%
1 month+2.78%
52-week high$61.70
52-week low$45.81
Volume4.47M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GSK earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.47 | $1.40 | +5.00% |
| Jun 2026 | Jul 28, 2026 | $1.36 | $1.27 | +7.09% |
| Mar 2026 | Apr 29, 2026 | $1.24 | $1.17 | +5.98% |
| Dec 2025 | Feb 4, 2026 | $0.68 | $0.64 | +6.25% |
GSK beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GSK
SEC filing data is not available right now. You can search for GSK on SEC EDGAR.
GSK news
- GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology CaseNov 1, 2026 · finance.yahoo.com
- GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Oct 29, 2026 · finance.yahoo.com
- Chiesi Group appoints Paolo Paoletti to its Board of DirectorsOct 29, 2026 · finance.yahoo.com
- GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention?Oct 29, 2026 · finance.yahoo.com
- Genmab Stock Surges to Record High After Stunning Cancer Drug ResultsOct 28, 2026 · finance.yahoo.com
- Glaxo: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
- What GSK (GSK) Said on Its Q3 Earnings CallOct 28, 2026 · marketbeat.com
- GSK Fumbles On Vaccines, HIV — Reversing An 11% Pre-Earnings RunOct 28, 2026 · finance.yahoo.com
About GSK plc
GSK plc (GSK) is a US-listed public company on NYSE.